Thérapie photodynamique et carcinomes urothéliaux

Translated title of the contribution: Photodynamic therapy and urothelial carcinoma

Pierre Colin, Juan Pablo Estevez, Nacim Betrouni, Pierre Nevoux, Philippe Puech, Xavier Leroy, Jacques Biserte, Arnauld Villers, Serge Mordon

    Research output: Contribution to journalReview Articlepeer-review

    2 Citations (Scopus)

    Abstract

    Purpose. Photodynamic therapy (PDT) is an innovative therapeutic modality in urologic oncology. Material and methods. We reviewed the current literature on principles and modalities of PDT in urothelial and penile oncology. Results. PDT has been tested for the treatment recurrent superficial bladder tumors and in situ carcinoma. Carcinologic efficacy has been observed with first generation photosensitizer. The lack of selectivity for tumoral cells was responsible of serious adverse events. Development of selective photosensitizers has reduced the importance of side effects. Data concerning PDT for upper urinary tract and urethra carcinoma are still limited. Conclusion. First PDT clinical applications in urothelial oncology have shown some effectiveness at the cost of significant morbidity. The development of selective photosensitizers should help to reduce side effects.

    Translated title of the contributionPhotodynamic therapy and urothelial carcinoma
    Original languageFrench
    Pages (from-to)769-778
    Number of pages10
    JournalBULLETIN DU CANCER
    Volume98
    Issue number7
    DOIs
    Publication statusPublished - Jul 2011
    Publication typeA2 Review article in a scientific journal

    Keywords

    • Bladder
    • Photodynamic therapy
    • Upper urinary tract
    • Urethra
    • Urothelial carcinoma

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research
    • Radiology Nuclear Medicine and imaging
    • Hematology

    Fingerprint

    Dive into the research topics of 'Photodynamic therapy and urothelial carcinoma'. Together they form a unique fingerprint.

    Cite this